Amalgamated Financial’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Amalgamated Financial's PDLI Position: Q1 2022 in Review
Amalgamated Financial opened a new position in PDL BioPharma, Inc. (PDLI) in Q1 2022: 8,806 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2727 among its holdings.
5 funds tracked by Wall St. Rank hold PDLI as of Q1 2022.
- Amalgamated Financial held 8,806 shares of PDL BioPharma, Inc. worth $22K as of Q1 2022.
- PDL BioPharma, Inc. was a new Amalgamated Financial position in Q1 2022.
- PDL BioPharma, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2727 holding.
- 5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2022.
Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.